|
|||||
|
|
| 中药新药临床试验对照药选择的问题与对策 | |
| 引用本文： | 向楠,邓阿黎,邓兰琼,翟华强,李晓东. 中药新药临床试验对照药选择的问题与对策[J]. 中国临床药理学与治疗学, 2005, 10(5): 598-600 |
| 作者姓名： | 向楠 邓阿黎 邓兰琼 翟华强 李晓东 |
| 作者单位： | 湖北省中医院国家药品临床研究基地,武汉,430061,湖北 |
| 摘 要： | 对照药的选择是中药新药临床试验过程中的一个重要环节，直接关系到，临床试验的质量，本归纳了目前中药临床试验过程中对照药选择的若干问题，并提出解决问题的对策和建议。 |
| 关 键 词： | 中药新药 临床试验 对照药 CCP |
| 文章编号： | 1009-2501(2005)05-0598-03 |
| 修稿时间： | 2004-12-08 |
Problems and countermeasures of choice of control drug in clinical trials of the traditional Chinese new drug |
|
| XIANG Nan,DENG A-li,DENG Lan-qiong,ZHAI Hua-qiang,LI Xiao-dong. Problems and countermeasures of choice of control drug in clinical trials of the traditional Chinese new drug[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 598-600 | |
| Authors: | XIANG Nan DENG A-li DENG Lan-qiong ZHAI Hua-qiang LI Xiao-dong |
| Affiliation: | XIANG Nan,DENG A-li,DENG Lan-qiong,ZHAI Hua-qiang,LI Xiao-dongBasis of GCP,Traditional Chinese Medicine Hospital of Hubei Province,Wuhan 430061,Hubei,China |
| Abstract: | The choice of control drug is an important factor in the clinical trial of the traditional Chinese drug, and it directly relates to the quality of clinical trial. This paper lists several problems about the choice of control drug and puts forward some proposal and countermeasures. |
| Keywords: | traditional Chinese drug control clinical trial GCP |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |